Bill McKenzie

Experience

• 

  MilliporeSigma

  May 1993 - Jun 2005

  P&L accountability for a global medical products & diagnostic membranes business. Built a strong international team of scientists, engineers, product marketing and sales individuals to drive the business. Negotiated and managed multi-million dollar contracts with key accounts including Abbott, Baxter, Roche, and Bayer. Championed a capital investment plan for a state of the art diagnostic membrane manufacturing facility that secured Millipore’s leadership position for highest quality membranes in the market. Drove strong double digit sales growth of diagnostic membranes for over 4 years Show less

  • Strategic Marketing Director, BioScience

    May 1999 - Jun 2005

  • General Manager, OEM Healthcare

    May 1993 - May 1999
• 

  PerkinElmer

  Sept 2005 - Dec 2012

  P&L accountability for a global molecular diagnostic start up focused on Human Genetics and Pathogen Testing with a strong emphasis on emerging markets including China and India. Forged KOL partnerships in the US, Europe, Hong Kong, India and China that validated the clinical utility of the products resulting in accelerated market adoption.Spearheaded the strategic plan focusing on portfolio, market and channel expansion fortifying PerkinElmer’s leadership position in maternal fetal health globally and infectious disease diagnostics in China. Launched several game changing products providing earlier, more sensitive detection, for better patient outcomes. Annual sales grew 40% per year. Collaborated with business development on due diligence and integration of 2 acquisitions that expanded the portfolio and access to regional markets. Show less Identified & prioritized regional opportunities, developed go to market strategies, assessed & integrated acquisition targetsCollaborated with business partners to identify, assess, acquire and integrate several acquisition targets. Led due diligence & integration of NTD Labs, which helped maintain the prenatal market leadership in the US market. Led the integration of Viacell, which expanded the product portfolio and sales channel access to OB/GYN’s and direct to consumer markets in the US. Established a clinical service lab model for the Indian market and collaborated with BD to acquire and integrate Surrendra Genetics Labs as a foundation for growth in India. Collaborated with BD and other business partners to develop a go to market strategy for China, participated in the assessment of local acquisition targets, and led the marketing due diligence and integration of Symbio Diagnostics, a leading Shanghai based kit maker. Show less Built and drove best practice processes for product management and marketing communications teams in this life science research and drug discovery business. Spearheaded the development of transformative strategic and tactical planning processes, developed tools to streamline the process, linked strategy to tactics, focused the team on key components and priorities that drove success through accountability and fact based management. • Established collaborations with key Mass Spec and Protein Immunoassay researchers at Johns Hopkins, George Mason, U. of Toronto, and U. of Texas to identify superior biomarkers for prenatal screening and preeclampsia. Show less

  • Vice President & General Manager, Molecular Diagnostics Business

    Aug 2010 - Dec 2012

  • Global Business Director, Genetic Screening Business

    Dec 2007 - Jul 2010

  • Strategic Marketing Director, Molecular Medicine

    Sept 2005 - Nov 2007
• 

  Upstart Life Science

  Jan 2013 - Jan 2019

  Founding Partner

  Upstart is a management consultancy, enabling early stage life science tools and diagnostic product companies to achieve success by improving strategies and performance. Services include market analysis, business and financial modeling, strategic planning, commercialization plan construction, team building, M&A

• 

  WaferGen Biosystems

  Jan 2013 - Jan 2017

  Other Board of Directors and Advisory Positions

  Member, Board of DirectorsWafergen, Inc (2014 - 2017)WaferGen, a publicly traded biotechnology company in Freemont, CA, offers innovative genomic technology solutions for single-cell analysis and clinical research in the life sciences, pharmaceutical, and clinical laboratory industries. In addition to board member responsibilities, I served on the Audit and Compensation committees.Member, Board of Directors Quad Technologies, Woburn, MA (2013 - 2015) Focused on the design and manufacture of innovative cell separation technology to isolate and purify stem cells in biological samples. Show less

• 

  SeqWell

  Jan 2016 - Jan 2020

  Member Board Of Directors

  seqWell has developed a transformative suite of library prep solutions for DNA sequencing that redefine the standards for throughput and output (effective read length) of any DNA sequencer. Their engineered molecular reagent platform allows users to process orders of magnitude more samples for any DNA sequencer with less time and cost, and retrieve long range information that resolves full-length phased DNA sequences. These improvements in productivity, accuracy, uniformity all reside within a streamlined, easily integrated workflow. Show less

• 

  Tempus Ventures

  Mar 2016 - Dec 2017

  Managing Partner

  Our mission is to partner with visionary founders in early stage life science start-ups to develop, refine and co-exist in bringing transformative technologies and products to market. Our services consist of, but are not limited to, strategic business operations, strategic marketing development, persistent R&D support, capitalization and exit strategies. Upon engagement, we develop a robust validation plan and exit strategy. Then, working with company leadership, we manage to a maximum value exit. Show less

• 

  Intus Bio

  Feb 2019 - now

  Shoreline Biome’s mission is to enable the rapid and quantitative enumeration of the entire microbiome to strain level resolution, through its transformative technologies. Insights gained from microbiome research will ultimately lead to powerful bio-therapeutics and diagnostics. It’s just a matter of time, and Shoreline Biome is leading the way.

  • Advisor

    Nov 2022 - now

  • Executive Chairman

    Mar 2021 - Nov 2022

  • CEO

    Feb 2019 - Mar 2021